These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31966719)

  • 1. Serum Golgi protein 73 is a prognostic biomarker of liver transplantation patients.
    Wang Y; Zhang Z; Zou D; Hao Q; Ma X; Wang C; Zhang J; Zhang X; Wang B; Wang X; Yang X
    Int J Clin Exp Pathol; 2017; 10(8):8626-8632. PubMed ID: 31966719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma.
    Jiao C; Cui L; Piao J; Qi Y; Yu Z
    J Cancer Res Ther; 2018; 14(6):1239-1244. PubMed ID: 30488837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
    Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
    Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
    Xu WJ; Guo BL; Han YG; Shi L; Ma WS
    Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.
    Li B; Liu A; Wen Y; Yang G; Zhao J; Li X; Mao Y; Li B
    J Clin Lab Anal; 2021 Sep; 35(9):e23932. PubMed ID: 34403527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
    Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
    PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
    Hu B; Tian X; Sun J; Meng X
    Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.
    Hu JS; Wu DW; Liang S; Miao XY
    Med Oncol; 2010 Jun; 27(2):339-45. PubMed ID: 19399652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
    J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer.
    Loosen SH; Halpaap J; Labuhn S; Bednarsch J; Alizai PH; Roeth AA; Lang SA; Vucur M; Kather JN; Knoefel WT; Ulmer TF; Neumann UP; Roderburg C; Luedde T
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
    Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
    J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
    Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
    Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
    Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
    Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
    Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
    Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.